Display options
Share it on

Cent European J Urol. 2013;66(2):196-9. doi: 10.5173/ceju.2013.02.art21. Epub 2013 Aug 13.

Chronic prostatitis/chronic pelvic pain syndrome: the role of an antifungal regimen.

Central European journal of urology

Ahmed Fouad Kotb, Asmaa Mohamed Ismail, Mohamed Sharafeldeen, Elsayed Yahia Elsayed

Affiliations

  1. University of Alexandria, Faculty of Medicine, Department of Urology, Alexandria, Egypt.

PMID: 24579027 PMCID: PMC3936149 DOI: 10.5173/ceju.2013.02.art21

Abstract

INTRODUCTION: The role of fungal infection as a causative factor for prostatitis is currently underestimated. The aim of our work was to evaluate the response to an antifungal regimen in the setting of patients presenting with symptoms of chronic pelvic pain syndrome that have been refractory to treatment with antibiotics and alpha-blockers.

MATERIAL AND METHODS: We included 1,000 consecutive patients. The inclusion criteria included failure of response to four consecutive weeks of antibiotic and alpha-blockers. The antifungal regimen was continued for two weeks. It included a low carbohydrate diet, the alkalinization of urine, and administration of fluconazole.

RESULTS: The mean age of the patients was 34 years. Mean serum total PSA and PSA density (PSAd) were 0.6 ng/ml and 0.03 ng/ml/gram, respectively. The mean age, PSA, prostate volume, and PSAd for patients that showed good response were 33, 0.5, 17, and 0.031, respectively. Values for patients that did not show good response were 36, 0.8, 23, and 0.037, respectively (p <0.0001 for all of the variables). Improvement was observed in 80% of cases treated with the antifungal regimen.

CONCLUSIONS: Antifungal regimen should be considered for the majority of young adult men, presenting with chronic prostatitis/ chronic pelvic pain syndrome and incomplete response to antibiotics.

Keywords: antifungal; candida; chronic pelvic pain syndrome; prostatitis

References

  1. Rev Inst Med Trop Sao Paulo. 2007 Nov-Dec;49(6):349-53 - PubMed
  2. Maedica (Bucur). 2010 Dec;5(4):277-9 - PubMed
  3. J Urol. 1998 Apr;159(4):1224-8 - PubMed
  4. J Assoc Physicians India. 1970 May;18(5):497-502 - PubMed
  5. Clin Infect Dis. 2011 May;52 Suppl 6:S437-51 - PubMed
  6. J Urol. 1995 Aug;154(2 Pt 1):407-13 - PubMed
  7. J Urol. 2005 Jul;174(1):161-4 - PubMed
  8. Korean J Urol. 2012 Jan;53(1):50-3 - PubMed
  9. Med Mycol. 2006 May;44(3):261-6 - PubMed
  10. Arch Ital Urol Androl. 2005 Jun;77(3):155-6 - PubMed
  11. Infect Immun. 1983 Mar;39(3):1354-60 - PubMed
  12. JAMA. 2011 Jan 5;305(1):78-86 - PubMed
  13. Urology. 2006 Feb;67(2):337-42 - PubMed
  14. Urol Int. 1992;48(3):362-4 - PubMed
  15. Eur Urol. 1996;30(1):24-7 - PubMed
  16. J Urol. 2000 Jan;163(1):244 - PubMed
  17. Urol Int. 2001;67(2):186-8 - PubMed

Publication Types